-
SynRx Therapeutics presents data on the PARG inhibitor program SYN608 at the 36t...
SynRx Therapeutics announces the presentation of its PARG inhibitor program at at the 36th EORTC-NCI-AACR Symposium
MORE -
A Best-in-Class Polθ Inhibitor SYN818 from SynRx Therapeutics Received IND Clear...
A Best-in-Class Polθ Inhibitor SYN818 from SynRx Therapeutics Received IND Clearance from U.S. FDA
MORE -
AACR Annual Meeting 2024 grandly opens, SynRx Therapeutics presented the latest ...
April 5, AACR Annual Meeting (AACR 2024) opened at the San Diego Convention Center, San Diego, California. SynRx Therapeutics attended the meeting and presented the latest preclinical data from the project in the form of posters.
MORE -
AACR Annual Meeting 2023 opens today, SynRx Therapeutics presented data from two...
SynRx Therapeutics attended the meeting and presented the latest preclinical data from the two projects in the form of posters .
MORE
